Q1 2023 EPS Estimates for UnitedHealth Group Incorporated Decreased by SVB Leerink (NYSE:UNH)

UnitedHealth Group Incorporated (NYSE:UNHGet Rating) – Stock analysts at SVB Leerink lowered their Q1 2023 EPS estimates for UnitedHealth Group in a research report issued on Tuesday, January 17th. SVB Leerink analyst W. Mayo now expects that the healthcare conglomerate will earn $6.07 per share for the quarter, down from their previous estimate of $6.09. SVB Leerink currently has a “Outperform” rating and a $618.00 price objective on the stock. The consensus estimate for UnitedHealth Group’s current full-year earnings is $24.82 per share. SVB Leerink also issued estimates for UnitedHealth Group’s Q3 2023 earnings at $6.55 EPS, Q4 2023 earnings at $6.07 EPS, FY2023 earnings at $24.93 EPS, Q4 2024 earnings at $6.99 EPS, FY2024 earnings at $28.56 EPS, FY2025 earnings at $32.92 EPS and FY2026 earnings at $38.10 EPS.

Several other equities analysts have also commented on the stock. UBS Group decreased their price objective on shares of UnitedHealth Group from $590.00 to $550.00 and set a “neutral” rating for the company in a research report on Wednesday. Morgan Stanley reaffirmed an “overweight” rating and set a $587.00 target price on shares of UnitedHealth Group in a research note on Wednesday, November 23rd. Royal Bank of Canada lifted their target price on shares of UnitedHealth Group from $588.00 to $592.00 and gave the stock an “outperform” rating in a research note on Monday, October 17th. Loop Capital lifted their price target on UnitedHealth Group from $575.00 to $590.00 in a report on Tuesday. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on UnitedHealth Group from $569.00 to $615.00 and gave the stock a “buy” rating in a report on Tuesday, October 18th. Three research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus price target of $599.28.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $484.36 on Wednesday. The firm has a market capitalization of $452.56 billion, a P/E ratio of 22.86, a PEG ratio of 1.35 and a beta of 0.73. The company has a quick ratio of 0.82, a current ratio of 0.77 and a debt-to-equity ratio of 0.67. The company has a 50 day moving average price of $519.94 and a 200 day moving average price of $524.48. UnitedHealth Group has a 52 week low of $445.73 and a 52 week high of $558.10.

UnitedHealth Group (NYSE:UNHGet Rating) last released its quarterly earnings results on Friday, January 13th. The healthcare conglomerate reported $5.34 EPS for the quarter, beating the consensus estimate of $5.17 by $0.17. The business had revenue of $82.79 billion during the quarter, compared to analyst estimates of $82.53 billion. UnitedHealth Group had a net margin of 6.21% and a return on equity of 27.04%. The company’s quarterly revenue was up 12.3% on a year-over-year basis. During the same period in the prior year, the firm posted $4.48 earnings per share.

Hedge Funds Weigh In On UnitedHealth Group

A number of institutional investors and hedge funds have recently added to or reduced their stakes in UNH. Wealthstream Advisors Inc. raised its stake in shares of UnitedHealth Group by 4.4% during the second quarter. Wealthstream Advisors Inc. now owns 452 shares of the healthcare conglomerate’s stock worth $232,000 after purchasing an additional 19 shares during the last quarter. CoreCap Advisors LLC boosted its stake in shares of UnitedHealth Group by 0.5% during the second quarter. CoreCap Advisors LLC now owns 4,217 shares of the healthcare conglomerate’s stock valued at $2,166,000 after acquiring an additional 19 shares during the last quarter. Elgethun Capital Management boosted its stake in shares of UnitedHealth Group by 0.3% during the second quarter. Elgethun Capital Management now owns 6,577 shares of the healthcare conglomerate’s stock valued at $3,369,000 after acquiring an additional 19 shares during the last quarter. Hollencrest Capital Management boosted its stake in shares of UnitedHealth Group by 0.8% during the third quarter. Hollencrest Capital Management now owns 2,337 shares of the healthcare conglomerate’s stock valued at $1,180,000 after acquiring an additional 19 shares during the last quarter. Finally, Smith Salley & Associates lifted its position in UnitedHealth Group by 0.7% during the third quarter. Smith Salley & Associates now owns 2,873 shares of the healthcare conglomerate’s stock worth $1,451,000 after buying an additional 19 shares during the period. 86.31% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 450 shares of the business’s stock in a transaction dated Wednesday, December 7th. The stock was sold at an average price of $542.30, for a total transaction of $244,035.00. Following the completion of the transaction, the executive vice president now directly owns 8,736 shares of the company’s stock, valued at $4,737,532.80. The sale was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 0.40% of the company’s stock.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 13th. Stockholders of record on Monday, December 5th were given a dividend of $1.65 per share. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.36%. The ex-dividend date was Friday, December 2nd. UnitedHealth Group’s dividend payout ratio is presently 31.15%.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Recommended Stories

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.